Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Heart Fail. 2010 Dec;12(12):1274-81. doi: 10.1093/eurjhf/hfq158. Epub 2010 Oct 5.

The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.

Author information

  • 1Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands.

Abstract

Nitric oxide (NO) is formed from arginine by the enzyme nitric oxide synthase (NOS). Asymmetric dimethylarginine (ADMA) can inhibit NO production by competing with arginine for NOS binding. Therefore, the net amount of NO might be indicated by the arginine/ADMA ratio. In turn, arginine can be metabolized by the enzyme arginase, and ADMA by the enzyme dimethylarginine dimethylaminohydrolase (DDAH). While ADMA has been implicated as a cardiovascular risk factor, arginine supplementation has been indicated as a treatment in cardiac diseases. This review discusses the roles of ADMA and arginine in the failing heart and its vasculature. Furthermore, it proposes nutritional therapies to improve NO availability.

PMID:
20923854
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk